Novel methods to assess the effectiveness of chemotherapy in AML patients: MRD
Paradigm-changing CAR T-cell therapy for multiple myeloma
Treatment at first relapse in multiple myeloma: how to choose a drug?
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich
An overview of immunotherapies for leukemia